Mortality and Serum Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein 3 Concentrations | Zendy

Nele Friedrich | Zendy; Robin Haring | Zendy; Matthias Nauck | Zendy; Jan Lüdemann | Zendy; Dieter Rosskopf | Zendy; E Spilcke-Liss | Zendy; Stephan B. Felix | Zendy; Marcus Dörr | Zendy; Georg Brabant | Zendy; Henry Völzke | Zendy; Henri Wallaschofski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mortality and Serum Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein 3 Concentrations

Author(s) -

Nele Friedrich,

Robin Haring,

Matthias Nauck,

Jan Lüdemann,

Dieter Rosskopf,

E Spilcke-Liss,

Stephan B. Felix,

Marcus Dörr,

Georg Brabant,

Henry Völzke,

Henri Wallaschofski

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-2138

Subject(s) - medicine , hazard ratio , confidence interval , prospective cohort study , proportional hazards model , population , endocrinology , insulin like growth factor , percentile , growth factor , receptor , environmental health , statistics , mathematics

Previous studies provided conflicting results regarding the association of serum IGF-I or IGF-binding protein-3 (IGFBP-3) and mortality. The aim of this study was to assess the relation of IGF-I and IGFBP-3 levels with mortality from all causes, cardiovascular disease (CVD), and cancer in a prospective population-based study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research